Elenbecestat (b)( E2609 | E-2609 )

Catalog No. M11611 CAS No. 1388149-39-0

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Elenbecestat (b)
Note

Research use only, not for human use.
Brief Description

Elenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.
Description

Elenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.Alzheimer's Disease Phase 3 Clinical.
In Vitro

——
In Vivo

——
Synonyms

E2609 | E-2609
Pathway

Metabolic Enzyme/Protease
Target

BACE
Recptor

BACE
Research Area

Neurological Disease
Indication

Alzheimer Disease

CAS Number

1388149-39-0
Formula Weight

491.4124
Molecular Formula

C19H15F6N5O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

FC(F)C1=CN=C(C(NC2=CC=C(F)C([C@]3(CO[C@@H]4C(F)(F)F)[C@]4([H])CSC(N)=N3)=C2)=O)C=N1
Chemical Name

N-(3-((4aS,5S,7aS)-2-amino-5-(trifluoromethyl)-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide